KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Gross Profit (2016 - 2026)

Amgen has reported Gross Profit over the past 18 years, most recently at $5.9 billion for Q1 2026.

  • For Q1 2026, Gross Profit rose 13.38% year-over-year to $5.9 billion; the TTM value through Mar 2026 reached $39.1 billion, up 57.91%, while the annual FY2025 figure was $35.4 billion, 72.32% up from the prior year.
  • Gross Profit for Q1 2026 was $5.9 billion at Amgen, down from $17.6 billion in the prior quarter.
  • Over five years, Gross Profit peaked at $17.6 billion in Q4 2025 and troughed at -$1.3 billion in Q4 2022.
  • A 5-year average of $6.1 billion and a median of $5.2 billion in 2023 define the central range for Gross Profit.
  • Biggest five-year swings in Gross Profit: tumbled 111.31% in 2022 and later soared 494.72% in 2023.
  • Year by year, Gross Profit stood at -$1.3 billion in 2022, then soared by 494.72% to $5.1 billion in 2023, then grew by 17.51% to $6.0 billion in 2024, then soared by 194.86% to $17.6 billion in 2025, then tumbled by 66.65% to $5.9 billion in 2026.
  • Business Quant data shows Gross Profit for AMGN at $5.9 billion in Q1 2026, $17.6 billion in Q4 2025, and $6.5 billion in Q3 2025.